JPS60139621A - 抗血栓剤 - Google Patents
抗血栓剤Info
- Publication number
- JPS60139621A JPS60139621A JP24486283A JP24486283A JPS60139621A JP S60139621 A JPS60139621 A JP S60139621A JP 24486283 A JP24486283 A JP 24486283A JP 24486283 A JP24486283 A JP 24486283A JP S60139621 A JPS60139621 A JP S60139621A
- Authority
- JP
- Japan
- Prior art keywords
- choline salicylate
- disorder
- antithrombotic agent
- useful
- choline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24486283A JPS60139621A (ja) | 1983-12-27 | 1983-12-27 | 抗血栓剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24486283A JPS60139621A (ja) | 1983-12-27 | 1983-12-27 | 抗血栓剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60139621A true JPS60139621A (ja) | 1985-07-24 |
JPH0410446B2 JPH0410446B2 (enrdf_load_stackoverflow) | 1992-02-25 |
Family
ID=17125092
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP24486283A Granted JPS60139621A (ja) | 1983-12-27 | 1983-12-27 | 抗血栓剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS60139621A (enrdf_load_stackoverflow) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1003501A4 (en) * | 1997-04-02 | 2001-01-17 | Brigham & Womens Hospital | MEANS OF EVALUATING THE RISK PROFILE OF AN INDIVIDUAL FOR ATHEROSCLERUS DISEASES |
US7030152B1 (en) | 1997-04-02 | 2006-04-18 | The Brigham And Women's Hospital, Inc. | Systematic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease |
US10101325B2 (en) | 2002-12-20 | 2018-10-16 | Sundrehagen, Erling, Dr. | Determination method for calprotectin and the use of calprotectin as a predictive marker for cardiovascular disease |
-
1983
- 1983-12-27 JP JP24486283A patent/JPS60139621A/ja active Granted
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1003501A4 (en) * | 1997-04-02 | 2001-01-17 | Brigham & Womens Hospital | MEANS OF EVALUATING THE RISK PROFILE OF AN INDIVIDUAL FOR ATHEROSCLERUS DISEASES |
EP1493439A1 (en) * | 1997-04-02 | 2005-01-05 | The Brigham And Women's Hospital, Inc. | Means of ascertaining an individual' s risk profile for atherosclerotic disease |
US7030152B1 (en) | 1997-04-02 | 2006-04-18 | The Brigham And Women's Hospital, Inc. | Systematic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease |
EP2305235A1 (en) * | 1997-04-02 | 2011-04-06 | The Brigham And Women's Hospital, Inc. | Means of ascertaining an individual's risk profile for atherosclerotic disease |
EP2305236A1 (en) * | 1997-04-02 | 2011-04-06 | The Brigham And Women's Hospital, Inc. | Means of Ascertaining an Individual's Risk Profile for Atherosclerotic Disease |
US7964614B2 (en) * | 1997-04-02 | 2011-06-21 | The Brigham And Women's Hospital, Inc. | Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease |
US10101325B2 (en) | 2002-12-20 | 2018-10-16 | Sundrehagen, Erling, Dr. | Determination method for calprotectin and the use of calprotectin as a predictive marker for cardiovascular disease |
Also Published As
Publication number | Publication date |
---|---|
JPH0410446B2 (enrdf_load_stackoverflow) | 1992-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3795739A (en) | Treatment of parkinson disease | |
JP5757677B2 (ja) | 門脈圧亢進症の予防及び/又は治療 | |
US4210670A (en) | Antithrombotic agents | |
HUP0400644A2 (hu) | Aszpirint tartalmazó gyógyászati kézítmények | |
JPH04504726A (ja) | アナフィラキシーの遅反応性物質に対する拮抗薬としてのリポキシンa↓4およびその誘導体の使用 | |
JPS6169722A (ja) | 医薬用組成物 | |
TWI331920B (en) | Unit dosage form for relieving or treating constipation in human patients | |
US4694024A (en) | Combination product composed of pyrimido-pyrimidines and O-acetylsalicylic acid or its pharmacologically tolerated salts, and its use | |
Kleiman et al. | Left ventricular dynamics during long-term digoxin treatment in patients with stable coronary artery disease | |
JPS60139621A (ja) | 抗血栓剤 | |
JP2002255814A (ja) | アスピリンを含有する医薬組成物 | |
JPH04501419A (ja) | 高血圧症の治療 | |
KR100907938B1 (ko) | 발기 기능장애의 치료를 위한 알카노일 l-카르니틴의 용도 | |
JP2003503448A (ja) | 心臓疾患の治療のためのコルチゾール拮抗剤の使用 | |
JPH01131113A (ja) | 脳障害治療剤 | |
Haldane | Coarctation of the aorta in an elderly man | |
JPH0445494B2 (enrdf_load_stackoverflow) | ||
JPS6396124A (ja) | アニパミル含有医薬 | |
JPH09227371A (ja) | 粥状動脈硬化抑制剤 | |
JPS625923A (ja) | アレルギ−性疾患治療剤 | |
US4555510A (en) | Therapeutic agent for hypertension | |
US4579852A (en) | Agent for avoiding occlusion of shunts in substitute blood tubes | |
KR0169118B1 (ko) | 치료에 유용한 혈소판 항-응집 효과를 갖는 조성물 | |
JPH0220608B2 (enrdf_load_stackoverflow) | ||
JPS6358809B2 (enrdf_load_stackoverflow) |